Validation of the Chronic Airways Assessment Test in the NOVELTY Study

Erin  Tomaszewski; Mark J.  Atkinson; Christer Janson; Niklas Karlsson; Barry Make; David Price; Helen K.  Reddel; Claus F Vogelmeier; Hana  Müllerová; Paul Jones

doi:10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1661

Validation of the Chronic Airways Assessment Test in the NOVELTY Study

Erin Tomaszewski
, Mark J. Atkinson
, Christer Janson
, Niklas Karlsson
, Barry Make
, David Price
, Helen K. Reddel
, Claus F Vogelmeier
, Hana Müllerová
, Paul Jones

AstraZeneca, Gaithersburg
Uppsala University
AstraZeneca Sweden
University of Colorado Denver
University of Sydney
AstraZeneca
GlaxoSmithKline
Evidera
Observational and Pragmatic Research Institute Singapore

Research output: Contribution to journal › Abstract › peer-review

34 Downloads (Pure)

Abstract

Very few patient-reported tools assess health status across different obstructive lung diseases. The Chronic Airways Assessment Test (CAAT) is a modification of the chronic obstructive pulmonary disease (COPD) Assessment Test (CAT) that is intended to assess health status in patients
with asthma and/or COPD.

Original language	English
Article number	A1661
Number of pages	1
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	203
Early online date	19 May 2021
DOIs	https://doi.org/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1661
Publication status	Published - 2021
Event	ATS International Conference Committee: ATS 2021 - Virtual event Duration: 14 May 2021 → 19 May 2021 https://conference.thoracic.org/

Access to Document

10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1661Licence: Unspecified

Tomaszewski_et_al_ATS21_ValidationOfTheChronic_AAM
Originally Published in: Tomaszewski, Abstract Validation of the chronic airways assessment test in the Novelty study. AJRCCM 2021;203:A1661. DOI:10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1661 Copyright © 2021 by the American Thoracic Society The final publication is available at https://www.atsjournals.org/doi/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1661
Accepted author manuscript, 916 KBLicence: Other

Cite this

Tomaszewski, E., Atkinson, M. J., Janson, C., Karlsson, N., Make, B., Price, D., Reddel, H. K., Vogelmeier, C. F., Müllerová, H., & Jones, P. (2021). Validation of the Chronic Airways Assessment Test in the NOVELTY Study. American Journal of Respiratory and Critical Care Medicine, 203, Article A1661. https://doi.org/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1661

@article{8152316754554a54bb42a5e14cb2f76a,

title = "Validation of the Chronic Airways Assessment Test in the NOVELTY Study",

abstract = "Very few patient-reported tools assess health status across different obstructive lung diseases. The Chronic Airways Assessment Test (CAAT) is a modification of the chronic obstructive pulmonary disease (COPD) Assessment Test (CAT) that is intended to assess health status in patients with asthma and/or COPD.",

author = "Erin Tomaszewski and Atkinson, \{Mark J.\} and Christer Janson and Niklas Karlsson and Barry Make and David Price and Reddel, \{Helen K.\} and Vogelmeier, \{Claus F\} and Hana M{\"u}llerov{\'a} and Paul Jones",

year = "2021",

doi = "10.1164/ajrccm-conference.2021.203.1\_MeetingAbstracts.A1661",

language = "English",

volume = "203",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "Oxford University Press",

note = "ATS International Conference Committee : ATS 2021 ; Conference date: 14-05-2021 Through 19-05-2021",

url = "https://conference.thoracic.org/",

}

TY - JOUR

T1 - Validation of the Chronic Airways Assessment Test in the NOVELTY Study

AU - Tomaszewski, Erin

AU - Atkinson, Mark J.

AU - Janson, Christer

AU - Karlsson, Niklas

AU - Make, Barry

AU - Price, David

AU - Reddel, Helen K.

AU - Vogelmeier, Claus F

AU - Müllerová, Hana

AU - Jones, Paul

PY - 2021

Y1 - 2021

N2 - Very few patient-reported tools assess health status across different obstructive lung diseases. The Chronic Airways Assessment Test (CAAT) is a modification of the chronic obstructive pulmonary disease (COPD) Assessment Test (CAT) that is intended to assess health status in patients with asthma and/or COPD.

AB - Very few patient-reported tools assess health status across different obstructive lung diseases. The Chronic Airways Assessment Test (CAAT) is a modification of the chronic obstructive pulmonary disease (COPD) Assessment Test (CAT) that is intended to assess health status in patients with asthma and/or COPD.

U2 - 10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1661

DO - 10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1661

M3 - Abstract

SN - 1073-449X

VL - 203

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

M1 - A1661

T2 - ATS International Conference Committee

Y2 - 14 May 2021 through 19 May 2021

ER -

Validation of the Chronic Airways Assessment Test in the NOVELTY Study

Abstract

Access to Document

Fingerprint

Cite this